Valley is aware of the nationwide supply disruption of IV fluid solution due to Hurricane Helene, and wants to reassure the community that steps have been taken to ensure the situation will have no negative impact on our patients and the community.
According to the World Health Organization, high blood pressure is a significant global healthcare problem affecting more than one billion people worldwide and is directly associated with increased risks of heart attacks, stroke, heart failure, kidney disease, and death.
Renal denervation is a minimally invasive procedure to treat resistant hypertension – high blood pressure that does not respond well to multiple medications or medical treatment. The treatment targets nerves near the kidneys, which can become overactive and contribute to high blood pressure.
Approved by the U.S. Food and Drug Administration (FDA), the Symplicity Spyral™ renal denervation (RDN) system – also known as the Symplicity blood pressure procedure – is a minimally invasive procedure that targets nerves near the kidneys that can become overactive and cause high blood pressure.
The Symplicity blood pressure procedure helps reduce blood pressure when medications and lifestyle changes aren’t enough.
If you have resistant hypertension, renal denervation may be a good option for you. Your care team at Valley will discuss your options with you, as well as the risks and benefits of renal denervation.